Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25097 | 22173246 | Singapore Med J | Metabolic syndrome. | 2011 | Details |
| A25102 | 22169693 | Zhonghua Yu Fang Yi Xue Za Zhi | [Waist circumference reference values in Beijing versus the national values in detecting cardiovascular risk factors in 7-18 years old children]. | 2011 | Details |
| A25111 | 22162978 | Clin Lipidol | Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease. | 2011 | Details |
| A25137 | 22149719 | Ann Med | Mapping body fat distribution: a key step towards the identification of the vulnerable patient? | 2011 | Details |
| A25145 | 22140316 | Vasc Health Risk Manag | Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25172 | 22114515 | Int J Gen Med | Evaluation of atherosclerotic findings in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25186 | 22108148 | J Clin Lipidol | 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy. | 2011 | Details |
| A25188 | 22105730 | Minerva Gastroenterol Dietol | Nonalcoholic fatty liver disease: the concept and confusion. | 2011 | Details |
| A25189 | 22105311 | Eur J Nutr | Cardioprotective and hepatoprotective effects of ellagitannins from European oak bark (Quercus petraea L.) extract in rats. | 2011 | Details |
| A25194 | 22102439 | BMJ | Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. | 2011 | Details |
| A25203 | 22096112 | Eur J Endocrinol | Recent advances in cardiovascular aspects of polycystic ovary syndrome. | 2011 | Details |
| A25224 | 22081919 | HPB (Oxford) | Metabolic syndrome and hepatic resection: improving outcome. | 2011 | Details |
| A25226 | 22081615 | J Am Coll Nutr | Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease. | 2011 | Details |
| A25230 | 22074433 | Curr Pharm Des | Liver enzymes: potential cardiovascular risk markers? | 2011 | Details |
| A25240 | 22059109 | World J Hepatol | Role of ezetimibe in non-alcoholic fatty liver disease. | 2011 | Details |
| A25252 | 22043839 | Expert Opin Pharmacother | Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome. | 2011 | Details |
| A25253 | 22043827 | Expert Opin Pharmacother | Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions. | 2011 | Details |
| A25279 | 22013734 | Eur Rev Med Pharmacol Sci | Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. | 2011 | Details |
| A25284 | 22002020 | Curr Opin Lipidol | Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic. | 2011 | Details |
| A25293 | 21988593 | Diabet Med | Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities. | 2012 | Details |
| A25294 | 21987620 | World J Gastroenterol | JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. | 2011 | Details |
| A25299 | 21986643 | Curr Opin Lipidol | Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: an update. | 2011 | Details |
| A25315 | 21963564 | Biochim Biophys Acta | Liver triacylglycerol lipases. | 2011 | Details |
| A25317 | 21962038 | BMC Public Health | Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. | 2011 | Details |
| A25320 | 21958082 | Clin Transplant | Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more. | 2011 | Details |
| A25339 | 21948267 | Obes Surg | Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery. | 2011 | Details |
| A25356 | 21932374 | Liver Transpl | Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. | 2012 | Details |
| A25363 | 21918648 | Curr Gerontol Geriatr Res | Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly. | 2011 | Details |
| A25365 | 21905818 | Int J Pediatr Obes | Fatty liver disease in obese children--relation to other metabolic risk factors. | 2011 | Details |
| A25369 | 21912450 | World J Gastroenterol | Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. | 2011 | Details |
| A25374 | 21910085 | Adv Exp Med Biol | Glycosphingolipids and insulin resistance. | 2011 | Details |
| A25375 | 21910084 | Adv Exp Med Biol | Sphingolipids and hepatic steatosis. | 2011 | Details |
| A25376 | 21910083 | Adv Exp Med Biol | Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity. | 2011 | Details |
| A25379 | 21907177 | Am J Pathol | Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet. | 2011 | Details |
| A25387 | 21898634 | Ultrasound Obstet Gynecol | Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome. | 2012 | Details |
| A25391 | 21894552 | J Mol Med (Berl) | Genetic variants in candidate genes influencing NAFLD progression. | 2011 | Details |
| A25392 | 21894514 | Endocrine | Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments. | 2011 | Details |
| A25393 | 21894292 | Med Ultrason | Association between fatty liver disease and carotid atherosclerosis in patients with uncomplicated type 2 diabetes mellitus. | 2011 | Details |
| A25418 | 21876629 | World J Gastroenterol | Nutritional recommendations for patients with non-alcoholic fatty liver diseases. | 2011 | Details |
| A25420 | 21875310 | Crit Rev Clin Lab Sci | Non-alcoholic fatty liver disease. | 2011 | Details |
| A25437 | 21843565 | Arch Med Res | Treatment of atherogenic liver based on the pathogenesis of nonalcoholic fatty liver disease: a novel approach to reduce cardiovascular risk? | 2011 | Details |
| A25454 | 21816784 | J Clin Endocrinol Metab | Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I. | 2011 | Details |
| A25472 | 21795844 | J Endocrinol Invest | Increased prevalence of cardiovascular disease in Type 1 diabetic patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25483 | 21779332 | PLoS One | Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation. | 2011 | Details |
| A25489 | 21773052 | J Lipids | Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation. | 2011 | Details |
| A25499 | 21765869 | Therap Adv Gastroenterol | The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis. | 2011 | Details |
| A25501 | 21764273 | Nutr Metab Cardiovasc Dis | Obesity and metabolic syndrome: potential benefit from specific nutritional components. | 2011 | Details |
| A25505 | 21760546 | J Pediatr Gastroenterol Nutr | Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children. | 2012 | Details |
| A25511 | 21751850 | Platelets | The association between non-alcoholic hepatic steatosis and mean platelet volume in an obese Korean population. | 2011 | Details |
| A25514 | 21750929 | Dig Dis Sci | The relationship between arterial stiffness and nonalcoholic fatty liver disease. | 2011 | Details |
| A25541 | 21734385 | Dig Dis | ASH and NASH. | 2011 | Details |
| A25553 | 21718726 | J Hepatol | Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. | 2011 | Details |
| A25559 | 21711426 | Hepatol Res | NASH: A global health problem. | 2011 | Details |
| A25586 | 21688282 | Hepatology | The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. | 2011 | Details |
| A25601 | 21664615 | Atherosclerosis | Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease. | 2011 | Details |
| A25607 | 21655948 | Dig Dis Sci | Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. | 2011 | Details |
| A25628 | 21629037 | Am J Med Sci | Lipid targets during statin treatment in dyslipidemic patients affected by nonalcoholic fatty liver disease. | 2011 | Details |
| A25645 | 21602530 | Gut | Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25655 | 21577310 | World J Gastrointest Pharmacol Ther | Is there any progress in the treatment of non-alcoholic fatty liver disease? | 2011 | Details |
| A25665 | 21565479 | Nutr Metab Cardiovasc Dis | Management of metabolic syndrome in children and adolescents. | 2011 | Details |
| A25666 | 21564529 | Am J Transplant | Should metformin be our antiglycemic agent of choice post-transplantation? | 2011 | Details |
| A25670 | 21563361 | Eksp Klin Gastroenterol | [Advisability of using probiotics in the treatment of atherogenic dyslipidemia]. | 2011 | Details |
| A25673 | 21561340 | Metab Syndr Relat Disord | Oxidative stress is activated by free fatty acids in cultured human hepatocytes. | 2011 | Details |
| A25675 | 21560640 | Eksp Klin Gastroenterol | [Gastroenterological aspects of atherosclerosis]. | 2011 | Details |
| A25681 | 21556019 | Nat Rev Endocrinol | Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. | 2011 | Details |
| A25685 | 21546603 | Arterioscler Thromb Vasc Biol | Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation. | 2011 | Details |
| A25686 | 21545576 | Br J Pharmacol | Resistin: functional roles and therapeutic considerations for cardiovascular disease. | 2012 | Details |
| A25695 | 21534339 | Turk J Pediatr | Abdominal obesity is an independent risk factor for increased carotid intima- media thickness in obese children. | 2011 | Details |
| A25706 | 21520200 | Hepatology | Endpoints and clinical trial design for nonalcoholic steatohepatitis. | 2011 | Details |
| A25716 | 21513939 | Atherosclerosis | Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25719 | 21509233 | Sultan Qaboos Univ Med J | Non-Alcoholic Fatty Liver Disease (NAFLD) - Is it an Emerging Risk Factor for Coronary Artery Disease?: Preliminary study in a local Indian population. | 2010 | Details |
| A25720 | 21508207 | J Nutr | Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. | 2011 | Details |
| A25722 | 21504583 | Lipids Health Dis | High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway. | 2011 | Details |
| A25730 | 21499089 | Curr Opin Cardiol | Liver function tests and statins. | 2011 | Details |
| A25734 | 21497741 | Best Pract Res Clin Gastroenterol | Fibrosis in alcoholic and nonalcoholic steatohepatitis. | 2011 | Details |
| A25735 | 21495873 | Toxicol Mech Methods | Epigenetic priming of the metabolic syndrome. | 2011 | Details |
| A25771 | 21476786 | Ann Med | Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? | 2011 | Details |
| A25776 | 21472332 | Mol Med Rep | Mammalian target of the rapamycin pathway is involved in non-alcoholic fatty liver disease. | 2010 | Details |
| A25809 | 21438811 | Expert Rev Cardiovasc Ther | Hepatic steatosis and Type 2 diabetes: current and future treatment considerations. | 2011 | Details |
| A25821 | 21427524 | J Endocrinol Invest | Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence? | 2011 | Details |
| A25825 | 21425426 | Diabetes Metab Res Rev | Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do. | 2011 | Details |
| A25837 | 21411114 | Metabolism | Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial. | 2011 | Details |
| A25842 | 21403438 | Gan To Kagaku Ryoho | [Helicobacter pylori infection and liver diseases]. | 2011 | Details |
| A25855 | 21388346 | Curr Vasc Pharmacol | Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk? | 2011 | Details |
| A25870 | 21374659 | Hepatology | Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. | 2011 | Details |
| A25892 | 21348922 | Obes Rev | Cardiovascular benefits of bariatric surgery in morbidly obese patients. | 2011 | Details |
| A25894 | 21348181 | G Ital Cardiol (Rome) | [Non-alcoholic fatty liver disease: a new challenge for cardiologists]. | 2010 | Details |
| A25900 | 21342625 | Zhongguo Dang Dai Er Ke Za Zhi | [The prevalence of type 2 diabetes mellitus and prediabetes in children]. | 2011 | Details |
| A25910 | 21335212 | Transplant Proc | Metabolic syndrome in transplant patients: an academic or a health burden? | 2011 | Details |
| A25918 | 21328622 | Biofactors | Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease. | 2010 | Details |
| A25929 | 21317853 | G Ital Dermatol Venereol | Psoriasis: comorbidities and associations. | 2011 | Details |
| A25968 | 21254896 | Ann Med | Association of liver enzymes with metabolic syndrome and carotid atherosclerosis in young adults. The Cardiovascular Risk in Young Finns Study. | 2011 | Details |
| A25971 | 21251450 | Acta Dermatovenerol Croat | Metabolic comorbidities and psoriasis. | 2010 | Details |
| A25975 | 21248661 | Transplantation | NAFLD recurrence in liver transplant recipients. | 2011 | Details |
| A25979 | 21244687 | BMC Res Notes | Comparative nucleic acid transfection efficacy in primary hepatocytes for gene silencing and functional studies. | 2011 | Details |
| A25993 | 21226276 | Nihon Rinsho | [Chronic liver disease and arteriosclerosis]. | 2011 | Details |
| A26012 | 21205607 | Orv Hetil | [Role of the brain in the regulation of metabolism and energy expenditure: the central role of insulin, and insulin resistance of the brain]. | 2011 | Details |
| A26015 | 21198708 | Aliment Pharmacol Ther | Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. | 2010 | Details |
| A26029 | 21188334 | J Gastrointestin Liver Dis | An overview of nonalcoholic steatohepatitis: past, present and future directions. | 2010 | Details |
| A26053 | 21161009 | World J Hepatol | Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge. | 2010 | Details |